Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-002465
Filing Date
2025-07-25
Accepted
2025-07-25 16:33:11
Documents
4
Period of Report
2025-07-25

Document Format Files

Seq Description Document Type Size
1 6-K zk2533479.htm 6-K 15839
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 11325
3 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 254212
4 image0.jpg GRAPHIC 471029
  Complete submission text file 0001178913-25-002465.txt   931357
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 251152077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)